Skip to main content
American Journal of Respiratory and Critical Care Medicine logoLink to American Journal of Respiratory and Critical Care Medicine
. 2019 Jan 1;199(1):62–70. doi: 10.1164/rccm.201803-0435OC

Low to Moderate Air Pollutant Exposure and Acute Respiratory Distress Syndrome after Severe Trauma

John P Reilly 1,2,, Zhiguo Zhao 3, Michael G S Shashaty 1,2, Tatsuki Koyama 3, Jason D Christie 1,2,4,5,*, Paul N Lanken 1, Chunxue Wang 6, John R Balmes 5,7,8,*, Michael A Matthay 8,9, Carolyn S Calfee 8,9, Lorraine B Ware 6,10
PMCID: PMC6353017  PMID: 30067389

Abstract

Rationale: Exposure to air pollution has molecular and physiologic effects on the lung that may increase the risk of acute respiratory distress syndrome (ARDS) after injury.

Objectives: To determine the association of short- and long-term air pollutant exposures and ARDS risk after severe trauma.

Methods: We analyzed data from a prospective cohort of 996 critically ill patients presenting with acute trauma and an injury severity score greater than 15. Exposures to ozone, nitrogen dioxide, sulfur dioxide, carbon monoxide, and particulate matter less than 2.5 μm were assessed by weighted averages of daily levels from all monitors within 50 km of the geocoded location of a patient’s residence. Patients were followed for 6 days for the development of ARDS according to Berlin Criteria. The association between each exposure and ARDS was determined via multivariable logistic regression adjusting for potential confounders.

Measurements and Main Results: ARDS developed in 243 (24%) patients. None of the short-term exposures averaged over the 3 days before presentation was associated with ARDS, except sulfur dioxide, which demonstrated a nonlinear association. Nitrogen dioxide, sulfur dioxide, and particulate matter less than or equal to 2.5 μm in aerodynamic diameter exposure over the 6 weeks before presentation was significantly associated with ARDS (P < 0.05). All long-term exposures (3 yr) were associated with ARDS (P < 0.01) in adjusted models, despite exposure levels largely below U.S. and European Union air quality standards.

Conclusions: Long-term low- to moderate-level air pollutant exposure is associated with a greater risk of developing ARDS after severe trauma and represents a novel and potentially modifiable environmental risk factor for ARDS.

Keywords: air pollution, ARDS, acute lung injury, epidemiology, trauma


At a Glance Commentary

Scientific Knowledge on the Subject

Exposure to high levels of ambient air pollutants is associated with increased mortality and morbidity as well as with acute exacerbations of cardiovascular and pulmonary disease. A previous study identified an association between long-term elevated ozone exposure and an increased risk of acute respiratory distress syndrome (ARDS). In animal and cell models, there is substantial evidence that components of air pollution contribute to lung inflammation, oxidative stress, and injury.

What This Study Adds to the Field

We conducted an analysis of a large prospectively enrolled cohort of patients with severe trauma and identified associations between long-term exposure to elevated ozone, nitrogen dioxide, sulfur dioxide, carbon monoxide, and particulate matter less than or equal to 2.5 μm in aerodynamic diameter and risk of ARDS. To our knowledge, this is the first study to report independent associations between exposures to nitrogen dioxide, sulfur dioxide, carbon monoxide, and particulate matter less than or equal to 2.5 μm in aerodynamic diameter and ARDS risk, and validates previous findings of an association between exposure to ozone and ARDS. The average exposures largely fell below current U.S. Environmental Protection Agency and European Union air quality standards. These findings have implications for ARDS prevention and public health air pollution standards.

Similar to the compounds in cigarette smoke, the chemicals produced during the combustion of fossil fuels by motor vehicles and power plants are known to induce alveolar injury and vascular inflammation in animal and in vitro models (1, 2). Specifically, air pollutants induce oxidative stress, recruit inflammatory cells to the lung, and provoke release of cytokines, even at low to moderate levels, in rodent models. In humans, short- and long-term exposure to high levels of ambient air pollutants, including ozone and particulate matter, has been associated with decreased life expectancy and acute exacerbations of cardiovascular and pulmonary disease (38). However, whether exposure to low or moderate levels of ambient air pollutants increases the risk of specific acute respiratory diseases, such as the acute respiratory distress syndrome (ARDS), has not been well studied.

ARDS is a syndrome of noncardiogenic pulmonary edema and acute respiratory failure that is characterized by inflammation and alveolar capillary barrier dysfunction (9). In a recent multinational observational study, ARDS occurred in 7% of ICU admissions (10). Mortality in ARDS is greater than 30% despite improvements in supportive care and ventilator management (11). This high incidence and substantial morbidity and mortality identify ARDS as a major global public health concern. Severe traumatic injuries are a common precipitating factor for ARDS, with ARDS developing in an estimated 10–30% of critically ill trauma patients (12, 13). Although potentially modifiable environmental exposures have been reported to alter ARDS risk in the setting of a precipitating factor, such as severe trauma, including cigarette smoke (14), and alcohol abuse (15), only one study has examined ambient air pollutant exposure as a possible modifier of ARDS risk (16). In that study of 1,558 critically ill patients within the Tennessee region presenting with a variety of precipitating factors for ARDS, there was an independent association between increasing long-term ozone exposure and ARDS risk (16). This association was strongest in the subgroup of patients with trauma as their risk factor for ARDS. In this cohort, other air pollutants were not independently associated with ARDS; however, the low density of air pollutant monitors in the region studied likely limited exposure estimates. Of note, median ozone exposures in that study were in the low to moderate range, well below current U.S. and European standards, suggesting that even low-level air pollutant exposures could influence the risk of ARDS.

In the current study, the primary objective was to test the association of both short- and long-term exposure to ambient air pollutants and the risk of developing ARDS in a large cohort of critically ill patients presenting after severe trauma in a region with a high density of air pollutant monitors and low to moderate levels of ambient air pollutants. We hypothesized that long-term, but not short-term, exposures to low to moderate levels of the air pollutants ozone, nitrogen dioxide (NO2), sulfur dioxide (SO2), carbon monoxide (CO), and particulate matter less than or equal to 2.5 μm in aerodynamic diameter (PM2.5) would be associated with the development of ARDS in the setting of acute traumatic injury.

Some of the results of this study have been previously reported in the form of an abstract (17).

Methods

Additional methods are provided in the online supplement.

Study Population

We prospectively enrolled patients who presented to the University of Pennsylvania with acute traumatic injury and were subsequently admitted to the ICU between 2005 and 2015 (1821). Patients were included if they presented within 24 hours of injury, had an age greater than 13, and an injury severity score greater than 15 (22). Patients were excluded if they suffered isolated severe head injury or died or were discharged within 24 hours of presentation. The institutional review board of the University of Pennsylvania (Protocol #802428) approved the study with a waiver of informed consent.

Air Pollution Exposure

Short- and long-term air pollutant exposures were estimated using levels from the Environmental Protection Agency’s Aerometric Information Retrieval System collected before the date of presentation from all monitors within 50 km of a geocoded location of residence for each participant. Daily measurements of NO2, SO2, CO, and PM2.5 were obtained. Because ozone is typically monitored only during the day and in summer months, we restricted ozone data to the highest 8-hour average level to calculate daily exposure during available months.

We estimated patients’ addresses using the centroid of a patient’s zip + 4 postal code. Pollutant exposures were estimated by the inverse-distance–squared weighted average levels measured from all monitors within 50 km of the geocoded residence (5). Short-term exposures were estimated using average pollutant levels for the 3 days and 6 weeks before hospital admission. Long-term exposures were estimated as average pollutant levels for 3-year periods before admission. Additionally, in secondary analyses, we estimated average air pollutant exposure levels for 1- and 5-year periods.

ARDS Outcome

Patients enrolled in the Penn Trauma Cohort Study were followed for 6 days from presentation for the development of ARDS based on the Berlin Definition while intubated and mechanically ventilated (23). If an arterial blood gas was not available within 24 hours of a chest radiograph consistent with ARDS, the oxygen saturation as measured by pulse oximetry/FiO2 ratio was used to determine if a patient met the hypoxemia criteria for ARDS (24).

Statistical Analysis

Characteristics of patients with and without ARDS were compared using Pearson chi-square or Wilcoxon rank sum tests, as appropriate. To evaluate associations between the pollutant level and risk of ARDS we analyzed short-term (3-d lag), mid-term (6-wk average), and long-term (3-yr averages) exposures of ozone, NO2, SO2, CO, and PM2.5. Ozone and NO2 were analyzed together in a multivariable logistic regression model because of the inversely correlated nature of the two air pollutants. Specifically, ozone interacts with NO released nearby air pollution sources to generate NO2 and oxygen, resulting in the lowest levels of ozone in regions of high NO2. All other air pollutants were analyzed in separate models. In all models, we adjusted for the following prespecified potential confounders: age, race, sex, month of enrollment, smoking history, alcohol use, type of trauma (blunt vs. penetrating), massive transfusion of greater than or equal to 10 red blood cell units, pulmonary contusion, insurance status, median household income, distance to the hospital, Acute Physiology and Chronic Health Evaluation-III score, and injury severity score.

Additionally, we conducted a priori defined sensitivity analyses excluding patients with chest radiographs equivocal for ARDS (25), and using a more restrictive definition of ARDS including only moderate and severe cases (23). These sensitivity analyses were conducted to assess the impact of potential outcome misclassification bias given the substantial challenge of phenotyping ARDS. We also conducted a sensitivity analysis limiting to monitors within 15 km of a patient’s residence, and examined interactions between pollutant levels and smoking history, mechanism of injury, age, and race. Pollutant exposures were available in all included subjects; however, multiple imputation using chained equations was used in regression models to address missing confounder data (26, 27). The version implemented was the aregImpute function in rms R-package (28). Statistical significance was considered for two-sided P values less than 0.05. Data analyses were conducted using R version 3.3.

Results

Cohort Characteristics

The Penn Trauma Cohort enrolled 996 patients who met the inclusion and exclusion criteria for the current study, of whom 243 (24%) developed ARDS within 6 days of presentation (Figure 1). Patients that developed ARDS were more likely to be white, lived further from the hospital, and had higher injury severity and severity of illness scores then patients who did not develop ARDS (Table 1). The median number of air quality monitors within 50 km of a patient’s residence ranged from 14 to 28 depending on the pollutant (see Table E1 in the online supplement), a substantially higher density of monitors compared with our previous study in the Tennessee region (16). All enrolled patients lived within 50 km of at least one air quality monitor. The distribution of patient addresses and monitor locations within the Philadelphia region are shown in Figure 2. Median levels of each air pollutant averaged over 3 years are provided in Table 2. Notably, ozone exposure levels were lower in the Penn Trauma Cohort than in our prior Tennessee region VALID (Validating Acute Lung Injury Biomarkers for Diagnosis) study (16), and NO2 levels were higher. Correlations between individual patient’s 3-year average pollutant exposures were moderately positive, with the exception of an inverse correlation between ozone and NO2 (see Table E2). The distributions of ARDS cases, age, sex, race, injury severity score, distance to the hospital, and insurance status across quartiles of pollutant exposures were not uniform and are provided in Table 3. Subjects living closer to the hospital and nonwhite subjects had higher exposures to NO2 and CO, and lower exposures to ozone.

Figure 1.

Figure 1.

Enrollment flow diagram. Some subjects met more than one exclusion criteria. BSA = body surface area; CHF = congestive heart failure; ISS = injury severity score; MI = myocardial infarction.

Table 1.

Patient Clinical Characteristics by ARDS Diagnosis

Patient Characteristic No ARDS (n = 753) ARDS (n = 243) Total Population (n = 996) P Value
Age 36 (24–56) 40 (25–53) 38 (24–56) 0.937
Male sex 550 (73) 192 (79) 742 (75) 0.063
White race 341 (47) 129 (55) 470 (49) 0.052
APACHE III 40 (29–57) 54 (39–73.7) 42.5 (31–61) <0.001
ISS 22 (19–29) 26 (21–34) 24 (19–29) <0.001
Current smoker 303 (42) 93 (41) 396 (42) 0.705
Alcohol use 115 (15) 39 (16) 154 (16) 0.745
Medicare/federal/private insurance (vs. Medicaid/uninsured) 362 (48) 106 (44) 468 (47) 0.268
Distance to Penn, km 8.2 (3.9–22.9) 11.0 (4.3–28.7) 8.6 (4.0–24.2) 0.018
Median household income, ×$1,000 44 (31–72) 47 (32–75) 44 (31–74) 0.119

Definition of abbreviations: APACHE = Acute Physiology and Chronic Health Evaluation; ARDS = acute respiratory distress syndrome; ISS = injury severity score.

Data are reported as median (interquartile range) or n (%). P values were obtained using the Wilcoxon rank sum test for continuous variables or the chi-square test for categorical variables. Race was missing in 40 subjects, smoking status in 46, alcohol use in 8, insurance status in 6, and household income in 3.

Figure 2.

Figure 2.

Geographic distribution of patient addresses included in the current study and distribution of Environmental Protection Agency–approved air quality monitors in the Philadelphia region (black symbols). Counties are shaded from light to dark red based on patient enrollment and the number of patients for each county is indicated by the black number at the center of each county.

Table 2.

Median Levels of 3-Year Air Pollutant Exposure in the Penn Trauma and the Previously Studied Tennessee Region VALID Cohort (8)

Pollutant Penn Trauma (n = 996) VALID (n = 1,558) P Value
Ozone, ppb (summer only) 47.1 (45.5–48.2) 51.5 (49.0–53.5) <0.001
NO2, ppb 18.1 (15.9–19.9) 15.4 (8.3–16.8) <0.001
SO2, ppb 3.58 (2.12–4.65) 2.77 (2.37–3.07) <0.001
CO, ppm 0.287 (0.258–0.405) 0.677 (0.594–0.742) <0.001
PM2.5, μg/m3 12.2 (10.8–13.6) 13.2 (12.1–13.7) <0.001

Definition of abbreviations: PM2.5 = particulate matter less than or equal to 2.5 μm in aerodynamic diameter; VALID = Validating Acute Lung Injury Biomarkers for Diagnosis Study.

Data are reported as median (interquartile range). P values were obtained using the Wilcoxon rank sum test.

Table 3.

Patient Characteristics by Quartiles of 3-Year Exposure Estimates for Each Air Pollutant

Pollutant Quartiles ARDS (Case; %) Age (yr) Sex (Male; %) Race (White; %) ISS Distance (km) Medicare, Federal, Private Insurance (%)
Ozone, ppb Q1 (37.9–45.5) 25 32 (23–51) 81 24 24 (19–29) 5.2 (3.0–9.2) 42
Q2 (45.6–47.1) 17 33 (24–54) 74 37 22 (19–29) 5.4 (3.5–10.0) 56
Q3 (47.2–48.2) 27 40 (27–60) 73 56 24 (19–29) 9.4 (4.0–26.9) 48
Q4 (48.3–52.8) 29 42 (25–58) 70 79 25 (20–30) 26.4 (18.8–39.7) 43
P value 0.009 0.001 0.052 <0.001 0.008 <0.001 0.009
                 
SO2, ppb Q1 (0.52–2.12) 17 44 (26–63) 72 50 24 (19–29) 9.8 (5.2–23.2) 76
Q2 (2.13–3.58) 24 36 (24–53) 79 48 25 (20–29) 6.6 (3.7–22.5) 52
Q3 (3.59–4.65) 26 36 (24–51) 76 40 22 (19–29) 5.7 (3.3–19.4) 33
Q4 (4.66–7.35) 31 38 (24–52) 72 57 23 (19–29) 14.0 (4.7–32.0) 28
P value 0.006 0.008 0.226 0.002 0.154 <0.001 <0.001
                 
NO2, ppb Q1 (2.7–15.9) 25 44 (28–62) 69 81 25 (20–30) 31.3 (21.7–53.8) 60
Q2 (16.0–18.1) 25 40 (24–60) 69 63 24 (19–29) 12.2 (5.7–23.4) 52
Q3 (18.2–19.9) 20 33 (24–53) 77 31 22 (20–29) 5.3 (3.7–10.8) 47
Q4 (20.0–24.6) 28 32 (23–47) 82 22 21 (19–27) 3.6 (2.5–5.8) 30
P value 0.222 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001
                 
CO, ppb Q1 (0.043–0.258) 20 42 (26–61) 71 58 24 (19–29) 17.3 (4.9–34.9) 65
Q2 (0.259–0.287) 21 42 (26–58) 75 49 25 (19–29) 7.7 (4.1–19.4) 59
Q3 (0.288–0.405) 29 35 (23–52) 75 50 22 (19–29) 10.0 (4.1–27.3) 37
Q4 (0.406–0.771) 29 33 (24–47) 76 40 22 (19–27) 6.0 (3.4–15.0) 27
P value 0.017 <0.001 0.476 0.001 0.048 <0.001 <0.001
                 
PM2.5, μg/m3 Q1 (7.9–10.8) 18 44 (26–61) 73 49 24 (19–29) 8.8 (4.5–22.4) 72
Q2 (10.9–12.2) 25 38 (24–55) 76 54 24 (19–29) 9.6 (4.4–32.9) 55
Q3 (12.3–13.6) 26 37 (24–54) 73 48 22 (19–29) 9.4 (4.0–22.6) 37
Q4 (13.7–16.7) 30 36 (24–50) 76 46 22 (19–27) 6.4 (3.3–24.7) 25
P value 0.016 0.022 0.720 0.315 0.102 0.015 <0.001

Definition of abbreviations: ARDS = acute respiratory distress syndrome; ISS = injury severity score; PM2.5 = particulate matter less than or equal to 2.5 μm in aerodynamic diameter.

Data are reported as median (interquartile range) or %. P values were obtained using the Pearson chi-square test for categorical variables and Wilcoxon rank sum test for the continuous variables. Race was missing in 40 subjects, and insurance status in six. The table demonstrates the nonuniform distribution of unadjusted ARDS risk and potential confounders across the quartiles of air pollution exposure.

Long-Term Pollutant Exposure

In the long-term air pollutant exposure models, increased 3-year exposure to ozone, SO2, CO, and PM2.5 was associated with increased risk of ARDS (Table 3). Specifically, unadjusted ARDS risk ranged from 25% to 29% in the lowest and highest quartiles of 3-year ozone exposure, 17–31% for SO2 exposure, 20–29% for CO exposure, and 18–30% for PM2.5 exposure. In multivariable logistic regression models that adjusted for potential confounders, 3-year exposure estimates for all five of the measured air pollutants were strongly and independently associated with risk of ARDS (Table 4, Figure 3; see Table E3). Findings for 1 year and 5 years of exposure were similar (see Table E4).

Table 4.

Logistic Regression Analysis for the Association of Exposure to Individual Air Pollutants and ARDS Risk

Pollutant Three-Year Average Exposure
Six-Week Average Exposure
Three-Day Average Exposure
OR* (95% CI) P Value OR* (95% CI) P Value OR* (95% CI) P Value
Ozone 1.44 (1.12–1.86) 0.005 1.13 (0.88–1.46) 0.248 0.90 (0.64–1.26) 0.203
NO2 2.39 (1.72–3.33) <0.001 1.77 (1.28–2.43) 0.002 1.42 (0.99–2.04) 0.111
SO2 3.56 (2.40–5.28) <0.001 2.31 (1.61–3.31) <0.001 1.78 (1.26–2.50) 0.005
CO 1.92 (1.47–2.53) <0.001 1.23 (0.97–1.56) 0.157 1.15 (0.90–1.48) 0.385
PM2.5 3.58 (2.40–5.34) <0.001 1.59 (1.21–2.11) <0.001 1.05 (0.81–1.36) 0.715

Definition of abbreviations: ARDS = acute respiratory distress syndrome; CI = confidence interval; OR = odds ratio; PM2.5 = particulate matter less than or equal to 2.5 μm in aerodynamic diameter.

*

The ORs are for the comparison of the 75th to the 25th percentile for each air pollutant. All models controlled for age, race, sex, type of trauma (blunt vs. penetrating), massive transfusion of ≥10 red blood cell units or more, pulmonary contusion, enrollment month, smoking, alcohol use, insurance status, median household income, distance to trauma center, Acute Physiology and Chronic Health Evaluation-III, and injury severity score. Full details of these models are provided in Table E2.

The results for ozone and NO2 were from the ozone-NO2 bipollutant models.

Figure 3.

Figure 3.

Relationship between 3-year average air pollutant exposure and predicted risk or probability of acute respiratory distress syndrome in a logistic regression model controlling for age, race, sex, enrollment month, smoking, alcohol use, insurance status, median household income, distance to trauma center, Acute Physiology and Chronic Health Evaluation-III, and injury severity score. The ozone model was also adjusted for 3-year nitrogen dioxide exposure. The nitrogen dioxide model was also adjusted for 3-year ozone exposure. Gray bars represent 95% confidence intervals around the predicted risks. ARDS = acute respiratory distress syndrome; PM2.5 = particulate matter less than or equal to 2.5 μm in aerodynamic diameter.

Short-Term Pollutant Exposure

Three-day exposure estimates for ozone, NO2, CO, and PM2.5 were not associated with ARDS (Table 4). In multivariable models, increased 3-day exposure to SO2 was associated with increased risk of ARDS; however, the relationship was nonlinear with the third exposure quartile having the highest ARDS risk (Table 4; see Figure E1). Exposure estimates for NO2, SO2, and PM2.5 over the 6 weeks before presentation were associated with increased ARDS risk (Table 4). The estimated effect sizes (odds ratios) increased with longer durations of exposure in all of the pollutant exposures (Table 4). Pollutant exposure estimates at 6 weeks, 1 year, 3 years, and 5 years were all moderately correlated, with the long-term exposure more closely correlated than the 6-week exposure period (see Table E5).

Sensitivity Analyses

Restricting analyses to patients with definitive chest radiographs with or without ARDS (excluding equivocal patients) did not substantially change any reported results. Comparisons between moderate and severe ARDS with all other subjects also did not substantially change any reported results. Limiting exposure data to only air quality monitors within 15 km of a patient’s geocoded address did not substantially change our results (see Table E6). We did not identify significant statistical interactions between air pollutant exposures and smoking status, age, race, or mechanism of traumatic injury (blunt vs. penetrating).

Discussion

Among a cohort of patients presenting to a major metropolitan level 1 trauma center after severe trauma, long-term exposures to NO2, SO2, CO, PM2.5, and ozone were associated with the subsequent development of ARDS. These associations were independent of confounders including known ARDS risk factors, distance from the trauma center, and insurance status. Although a previous study reported an association between long-term ozone exposure with ARDS risk (16), and another between ozone and particulate matter exposure with ARDS mortality (29), to our knowledge, this represents the first study reporting associations between exposures to SO2, CO, and PM2.5 and ARDS risk. Additionally, this study has replicated the previously reported association between ozone exposure and ARDS risk after severe trauma and identified that higher exposure levels of a duration as short as 6 weeks are associated with ARDS risk for three pollutants, NO2, SO2, and PM2.5. The unadjusted difference in ARDS risk between the lowest and highest quartiles of exposure was largest for SO2 (14%) and PM2.5 (12%). We did not identify an association between short-term air pollution exposure levels during the 3 days before trauma and risk of ARDS, supporting the conclusion that exposures of at least 6-weeks duration are required to prime the lung for injury following severe traumatic injuries.

Several individual air pollutants formed predominately from the combustion of fossil fuels have well-established physiologic effects on the lung and have been associated with morbidity and mortality in humans. Particulate matter exposure has been linked to a decline in lung function (30, 31); exacerbations of chronic respiratory disease (6, 7); and the generation of reactive oxygen species, altered alveolar barrier functions, and recruitment of inflammatory cells (32, 33). Similarly, high-dose ozone exposure induces acute lung injury in animal models and causes airway inflammation in lower-dose controlled human exposures (34, 35). In large epidemiologic studies, ambient ozone has been associated with respiratory disease–related mortality and morbidity (4, 36). Although studied to a lesser degree, SO2 and NO2 have also been linked to increased airway hyperresponsiveness (37, 38), worsening lung function (39), and lung inflammation (40). Although CO poisoning has known detrimental effects on oxygen uptake and delivery, CO is unlike the other air pollutants in that it has antiinflammatory and antioxidant effects (41). In fact, low-dose CO is being evaluated as a potential therapy for ARDS (42). It is possible that the association observed in our study is a result of CO functioning as a marker of combustion-related air pollution mixtures, or alternatively that chronic low-dose CO exposure has distinct biologic effects relative to acute exposure. This wealth of previous evidence supports the biologic plausibility of our findings, although the specific mechanisms at play and the role of each air pollutant in ARDS alone or as a mixture remain unknown.

The average air pollution concentrations observed in our study were largely below the current European Union and U.S. air quality standards (43, 44). Despite low- to moderate-range exposures, we observed a significant increase in ARDS risk in a patient population that was mostly young, and largely healthy before acute traumatic injury. Our findings support the conclusion that air pollution impacts diverse individuals including those with no prior pulmonary or cardiac disease. Additionally, our findings raise concern that current efforts in the United States and other countries to relax air pollution standards may lead to an increased risk of ARDS after trauma, a complication of critical illness with high morbidity and mortality. The increased risk of ARDS among trauma patients also may indicate potential adverse pathologic effects of pollution on the lung with wider implications for health and disease.

In a previous study of 1,558 critically ill patients at risk for ARDS who presented to Vanderbilt University Medical Center, exposure to ozone but not to other pollutants, was associated with the development of ARDS (16). This risk was strongest in the subgroup of 552 patients with trauma as their ARDS risk factor and in patients who were current smokers. There are several reasons that our current study may have identified novel associations that were not identified in the prior study. First, the region of the country presenting to the University of Pennsylvania is geographically and demographically distinct from that of the previous study with different pollutant exposure levels. Second, exposure estimates in the current study were more precise because patients enrolled in the current study lived, on average, within 50 km of three to four times as many air quality monitors and had a distance to the closest monitor less than half that of the previous study. The higher density of air quality monitoring in the current study may have significantly reduced exposure misclassification, increasing the likelihood of identifying true associations. Lastly, although the current study is smaller, it included nearly twice as many trauma patients, the subgroup with the strongest association between ozone and ARDS risk in the prior study. We did not observe an interaction by smoking status in our current study; however, we acknowledge the high potential for misclassification of patient- or surrogate-assessed smoking status in an acute trauma population (14).

We observed a U-shaped association between ozone and ARDS. This finding is distinct from the previous study reporting a near linear association between ozone exposure and ARDS (16); however, the previous study was conducted in a significantly higher ozone exposure region of the United States. Almost no patients in the prior study had ozone exposure levels within the lowest quartile of ozone exposure observed in the Penn Trauma cohort. The likely reason for this U-shaped finding lies in the complex relationship of ozone with other air pollutants. Ozone is not directly emitted as a pollutant but rather is formed from the interaction of nitrogen oxides, volatile organic compounds, and sunlight (34). Increasing emissions of nitrogen oxides increase ozone production initially; however, in areas of the highest emissions (e.g., near roadways and industrial plants), nitrogen oxide reacts with ozone to generate NO2 resulting in the local depletion of ozone (36). These areas have the lowest levels of ozone, but the highest levels of other pollutants that may be contributing to ARDS risk as evidenced. Our data demonstrating an inverse relationship between ozone and NO2 exposure support the hypothesis that this interaction explains these results.

Our study has several strengths. First, we studied a large cohort of patients presenting with trauma from a racially, socioeconomically, and geographically diverse region of the United States with extensive Environmental Protection Agency monitoring of air pollutants. We limited the cohort to critically ill patients with an injury severity high enough to put them at risk for ARDS. Second, patients were prospectively enrolled and followed for the development of ARDS via extensive chest radiograph and chart review by two trained physician investigators. We included several sensitivity analyses varying the ARDS definition, none of which altered our results. Finally, we prospectively collected extensive potential confounders and performed multivariable regression to reduce the possibility of residual confounding.

Our study also has some limitations. First, we did not directly measure long-term exposure to air pollutants, but rather relied on estimates based on address of home residence provided at hospital admission. Information about patients’ prior addresses, occupational exposures, or time spent indoors versus outdoors was unavailable, potentially introducing exposure misclassification bias. Additionally, our analysis assumes patients did not change residences during the study period. Second, patients presented predominately from one geographic region of the country. However, the referral region to the University of Pennsylvania is heterogeneous, with diverse air pollutant exposures. Third, as in any observational study, residual confounding continues to be possible despite adjustment for measured potential confounders. Given the improvements in air pollution over the decade of observation and improvements in trauma care over the same time period, it is possible that an unmeasured confounder that also improved over time explains our results. However, the lack of an association between 3-day pollution exposures and ARDS argues against an unmeasured confounder, because all time periods of exposure would be similarly confounded.

Fourth, the collinearity of some air pollutants makes it difficult to determine the causal pollutants in our observational data and limits our ability to analyze multipollutant models. It is possible that one pollutant may be a marker of another rather than a causal mediator of increased ARDS risk. This collinearity might particularly be the case for CO, which could be serving as a marker of traffic-related air pollutant exposure rather than a mediator of lung injury in this study. Fifth, we did not replicate an interaction with tobacco seen in our prior study (16); however, we acknowledge the challenges in obtaining accurate smoking histories, particularly in trauma patients. Lastly, our data do not provide information regarding the potential mechanisms underlying the association between air pollution and ARDS.

In conclusion, we have identified an association between long-term exposure to multiple components of air pollution and the development of ARDS in a large cohort of critically ill trauma patients. Our study replicates the prior associations of exposure to ozone and ARDS risk in a geographically distinct cohort and extends them to include novel associations of particulate matter, SO2, and CO with ARDS. In addition, the overall exposure estimates were in the low to moderate range and on average fell below current Environmental Protection Agency and European Union air quality standards, thus suggesting that even low to moderate exposure levels may have significant adverse health effects that can predispose an individual to ARDS after major trauma. Our findings suggest multiple components of air pollution are potential modifiable risk factors for ARDS with important implications for ARDS prevention and public health.

Supplementary Material

Supplements
Author disclosures

Footnotes

Funded by NIH grants HL103836 (L.B.W.), HL125723 (J.P.R.), DK097307 (M.G.S.S.), HL110969 (C.S.C.), HL140026 (C.S.C.), and HL51856 (M.A.M.).

Author Contributions: J.P.R., Z.Z., and L.B.W. designed the study, acquired data, analyzed data, and wrote the manuscript. M.G.S.S., J.D.C., and P.N.L. designed the study, acquired data, and revised the manuscript. T.K. and C.W. analyzed data and revised the manuscript. J.R.B., M.A.M., and C.S.C. designed the study and revised the manuscript. All authors approved the final version of the manuscript and are accountable for all aspects of the work.

This article has an online supplement, which is accessible from this issue's table of contents at www.atsjournals.org.

Originally Published in Press as DOI: 10.1164/rccm.201803-0435OC on August 1, 2018

Author disclosures are available with the text of this article at www.atsjournals.org.

References

  • 1.Sun Q, Wang A, Jin X, Natanzon A, Duquaine D, Brook RD, et al. Long-term air pollution exposure and acceleration of atherosclerosis and vascular inflammation in an animal model. JAMA. 2005;294:3003–3010. doi: 10.1001/jama.294.23.3003. [DOI] [PubMed] [Google Scholar]
  • 2.Xu X, Jiang SY, Wang TY, Bai Y, Zhong M, Wang A, et al. Inflammatory response to fine particulate air pollution exposure: neutrophil versus monocyte. PLoS One. 2013;8:e71414. doi: 10.1371/journal.pone.0071414. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Di Q, Wang Y, Zanobetti A, Wang Y, Koutrakis P, Choirat C, et al. Air pollution and mortality in the Medicare population. N Engl J Med. 2017;376:2513–2522. doi: 10.1056/NEJMoa1702747. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Jerrett M, Burnett RT, Pope CA, III, Ito K, Thurston G, Krewski D, et al. Long-term ozone exposure and mortality. N Engl J Med. 2009;360:1085–1095. doi: 10.1056/NEJMoa0803894. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Pope CA, III, Ezzati M, Dockery DW. Fine-particulate air pollution and life expectancy in the United States. N Engl J Med. 2009;360:376–386. doi: 10.1056/NEJMsa0805646. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Balmes JR, Cisternas M, Quinlan PJ, Trupin L, Lurmann FW, Katz PP, et al. Annual average ambient particulate matter exposure estimates, measured home particulate matter, and hair nicotine are associated with respiratory outcomes in adults with asthma. Environ Res. 2014;129:1–10. doi: 10.1016/j.envres.2013.12.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Kariisa M, Foraker R, Pennell M, Buckley T, Diaz P, Criner GJ, et al. Short- and long-term effects of ambient ozone and fine particulate matter on the respiratory health of chronic obstructive pulmonary disease subjects. Arch Environ Occup Health. 2015;70:56–62. doi: 10.1080/19338244.2014.932753. [DOI] [PubMed] [Google Scholar]
  • 8.Winterbottom CJ, Shah RJ, Patterson KC, Kreider ME, Panettieri RA, Jr, Rivera-Lebron B, et al. Exposure to ambient particulate matter is associated with accelerated functional decline in idiopathic pulmonary fibrosis. Chest. 2018;153:1221–1228. doi: 10.1016/j.chest.2017.07.034. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Matthay MA, Ware LB, Zimmerman GA. The acute respiratory distress syndrome. J Clin Invest. 2012;122:2731–2740. doi: 10.1172/JCI60331. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Bellani G, Laffey JG, Pham T, Fan E, Brochard L, Esteban A, et al. LUNG SAFE Investigators; ESICM Trials Group. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA. 2016;315:788–800. doi: 10.1001/jama.2016.0291. [DOI] [PubMed] [Google Scholar]
  • 11.Rubenfeld GD, Caldwell E, Peabody E, Weaver J, Martin DP, Neff M, et al. Incidence and outcomes of acute lung injury. N Engl J Med. 2005;353:1685–1693. doi: 10.1056/NEJMoa050333. [DOI] [PubMed] [Google Scholar]
  • 12.Watkins TR, Nathens AB, Cooke CR, Psaty BM, Maier RV, Cuschieri J, et al. Acute respiratory distress syndrome after trauma: development and validation of a predictive model. Crit Care Med. 2012;40:2295–2303. doi: 10.1097/CCM.0b013e3182544f6a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Shah CV, Localio AR, Lanken PN, Kahn JM, Bellamy S, Gallop R, et al. The impact of development of acute lung injury on hospital mortality in critically ill trauma patients. Crit Care Med. 2008;36:2309–2315. doi: 10.1097/CCM.0b013e318180dc74. [DOI] [PubMed] [Google Scholar]
  • 14.Calfee CS, Matthay MA, Eisner MD, Benowitz N, Call M, Pittet JF, et al. Active and passive cigarette smoking and acute lung injury after severe blunt trauma. Am J Respir Crit Care Med. 2011;183:1660–1665. doi: 10.1164/rccm.201011-1802OC. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Moss M, Parsons PE, Steinberg KP, Hudson LD, Guidot DM, Burnham EL, et al. Chronic alcohol abuse is associated with an increased incidence of acute respiratory distress syndrome and severity of multiple organ dysfunction in patients with septic shock. Crit Care Med. 2003;31:869–877. doi: 10.1097/01.CCM.0000055389.64497.11. [DOI] [PubMed] [Google Scholar]
  • 16.Ware LB, Zhao Z, Koyama T, May AK, Matthay MA, Lurmann FW, et al. Long-term ozone exposure increases the risk of developing the acute respiratory distress syndrome. Am J Respir Crit Care Med. 2016;193:1143–1150. doi: 10.1164/rccm.201507-1418OC. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Reilly JP, Zhao Z, Shashaty MG, Christie JD, Lanken PN, Koyama T, et al. Air pollutant exposure is an independent risk factor for acute respiratory distress syndrome after severe trauma [abstract] Am J Respir Crit Care Med. 2018;197:A6193. doi: 10.1164/rccm.201803-0435OC. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Reilly JP, Bellamy S, Shashaty MG, Gallop R, Meyer NJ, Lanken PN, et al. Heterogeneous phenotypes of acute respiratory distress syndrome after major trauma. Ann Am Thorac Soc. 2014;11:728–736. doi: 10.1513/AnnalsATS.201308-280OC. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Reilly JP, Meyer NJ, Shashaty MGS, Feng R, Lanken PN, Gallop R, et al. ABO blood type A is associated with increased risk of ARDS in whites following both major trauma and severe sepsis. Chest. 2014;145:753–761. doi: 10.1378/chest.13-1962. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Reilly JP, Anderson BJ, Mangalmurti NS, Nguyen TD, Holena DN, Wu Q, et al. The ABO Histo-Blood Group and AKI in critically ill patients with trauma or sepsis. Clin J Am Soc Nephrol. 2015;10:1911–1920. doi: 10.2215/CJN.12201214. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Shashaty MG, Kalkan E, Bellamy SL, Reilly JP, Holena DN, Cummins K, et al. Computed tomography-defined abdominal adiposity is associated with acute kidney injury in critically ill trauma patients. Crit Care Med. 2014;42:1619–1628. doi: 10.1097/CCM.0000000000000306. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Baker SP, O’Neill B, Haddon W, Jr, Long WB. The injury severity score: a method for describing patients with multiple injuries and evaluating emergency care. J Trauma. 1974;14:187–196. [PubMed] [Google Scholar]
  • 23.Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, et al. ARDS Definition Task Force. Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012;307:2526–2533. doi: 10.1001/jama.2012.5669. [DOI] [PubMed] [Google Scholar]
  • 24.Rice TW, Wheeler AP, Bernard GR, Hayden DL, Schoenfeld DA, Ware LB National Institutes of Health, National Heart, Lung, and Blood Institute ARDS Network. Comparison of the SpO2/FIO2 ratio and the PaO2/FIO2 ratio in patients with acute lung injury or ARDS. Chest. 2007;132:410–417. doi: 10.1378/chest.07-0617. [DOI] [PubMed] [Google Scholar]
  • 25.Shah CV, Lanken PN, Localio AR, Gallop R, Bellamy S, Ma SF, et al. An alternative method of acute lung injury classification for use in observational studies. Chest. 2010;138:1054–1061. doi: 10.1378/chest.09-2697. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Little RRD. Statistical analysis with missing data. New York: Wiley; 1987. [Google Scholar]
  • 27.White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. Stat Med. 2011;30:377–399. doi: 10.1002/sim.4067. [DOI] [PubMed] [Google Scholar]
  • 28.Harrell F. Regression modeling strategies: with applications to linear models, logistic and ordinal regression, and survival analysis. 2015. 2nd ed. Heidelberg: Springer.
  • 29.Rush B, McDermid RC, Celi LA, Walley KR, Russell JA, Boyd JH. Association between chronic exposure to air pollution and mortality in the acute respiratory distress syndrome. Environ Pollut. 2017;224:352–356. doi: 10.1016/j.envpol.2017.02.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Rice MB, Ljungman PL, Wilker EH, Dorans KS, Gold DR, Schwartz J, et al. Long-term exposure to traffic emissions and fine particulate matter and lung function decline in the Framingham Heart Study. Am J Respir Crit Care Med. 2015;191:656–664. doi: 10.1164/rccm.201410-1875OC. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Downs SH, Schindler C, Liu LJ, Keidel D, Bayer-Oglesby L, Brutsche MH, et al. SAPALDIA Team. Reduced exposure to PM10 and attenuated age-related decline in lung function. N Engl J Med. 2007;357:2338–2347. doi: 10.1056/NEJMoa073625. [DOI] [PubMed] [Google Scholar]
  • 32.Pope CA, III, Bhatnagar A, McCracken JP, Abplanalp W, Conklin DJ, O’Toole T. Exposure to fine particulate air pollution is associated with endothelial injury and systemic inflammation. Circ Res. 2016;119:1204–1214. doi: 10.1161/CIRCRESAHA.116.309279. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Janssen NA, Strak M, Yang A, Hellack B, Kelly FJ, Kuhlbusch TA, et al. Associations between three specific a-cellular measures of the oxidative potential of particulate matter and markers of acute airway and nasal inflammation in healthy volunteers. Occup Environ Med. 2015;72:49–56. doi: 10.1136/oemed-2014-102303. [DOI] [PubMed] [Google Scholar]
  • 34.Mustafa MG. Biochemical basis of ozone toxicity. Free Radic Biol Med. 1990;9:245–265. doi: 10.1016/0891-5849(90)90035-h. [DOI] [PubMed] [Google Scholar]
  • 35.Mudway IS, Kelly FJ. An investigation of inhaled ozone dose and the magnitude of airway inflammation in healthy adults. Am J Respir Crit Care Med. 2004;169:1089–1095. doi: 10.1164/rccm.200309-1325PP. [DOI] [PubMed] [Google Scholar]
  • 36.Guarnieri M, Balmes JR. Outdoor air pollution and asthma. Lancet. 2014;383:1581–1592. doi: 10.1016/S0140-6736(14)60617-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Johns DO, Linn WS. A review of controlled human SO2 exposure studies contributing to the US EPA integrated science assessment for sulfur oxides. Inhal Toxicol. 2011;23:33–43. doi: 10.3109/08958378.2010.539290. [DOI] [PubMed] [Google Scholar]
  • 38.Folinsbee LJ. Does nitrogen dioxide exposure increase airways responsiveness? Toxicol Ind Health. 1992;8:273–283. [PubMed] [Google Scholar]
  • 39.Liu L, Poon R, Chen L, Frescura AM, Montuschi P, Ciabattoni G, et al. Acute effects of air pollution on pulmonary function, airway inflammation, and oxidative stress in asthmatic children. Environ Health Perspect. 2009;117:668–674. doi: 10.1289/ehp11813. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Barck C, Sandström T, Lundahl J, Halldén G, Svartengren M, Strand V, et al. Ambient level of NO2 augments the inflammatory response to inhaled allergen in asthmatics. Respir Med. 2002;96:907–917. doi: 10.1053/rmed.2002.1374. [DOI] [PubMed] [Google Scholar]
  • 41.Otterbein LE, Mantell LL, Choi AM. Carbon monoxide provides protection against hyperoxic lung injury. Am J Physiol. 1999;276:L688–L694. doi: 10.1152/ajplung.1999.276.4.L688. [DOI] [PubMed] [Google Scholar]
  • 42.Motterlini R, Otterbein LE. The therapeutic potential of carbon monoxide. Nat Rev Drug Discov. 2010;9:728–743. doi: 10.1038/nrd3228. [DOI] [PubMed] [Google Scholar]
  • 43.National Ambient Air Quality Standards — criteria air pollutants. Washington, DC: Environmental Protection Agency; NAAQS table. [accessed 2018 Mar 1]. Available from: https://www.epa.gov/criteria-air-pollutants/naaqs-table. [Google Scholar]
  • 44.European Commission Air Quality Standards. [accessed 2018 Mar 1]. Available from: http://ec.europa.eu/environment/air/quality/standards.htm.

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplements
Author disclosures

Articles from American Journal of Respiratory and Critical Care Medicine are provided here courtesy of American Thoracic Society

RESOURCES